Table 1.
FM | GL | GH | GH-SB | |
---|---|---|---|---|
IBW (g) | 7.70±0.05 | 7.71±0.03 | 7.70±0.03 | 7.72±0.04 |
FBW (g) | 50.60±0.26b | 58.80±0.54c | 45.09±0.70a | 52.29±1.31b |
WGR (%) | 557.22±3.33b | 663.60±6.95c | 485.57±9.15a | 579.14±17.06b |
SGR (%/day) | 3.36±0.01b | 3.63±0.02c | 3.15±0.05a | 3.42±0.08b |
SR (%) | 100.00±0.00 | 95.83±1.60 | 99.17±0.83 | 97.78±2.22 |
FCR | 0.81±0.05ab | 0.65±0.11a | 1.35±0.17c | 0.99±0.06b |
Value show means ± SE (n = 4); Significance was evaluated by one-way ANOVA followed by Tukey’s multiple range tests. FM, control diet; GL, containing 2% 11S diet, GH, containing 8% 11S diet, GH-SB, containing 8% 11S and 0.13% SB diet. IBW, initial body weight; FBW, final body weight; WGR, weight gain rate; SGR, specific growth rate; SR, survival rate; FCR, feed coefficient ratio. a, b, cMean values among all treatments with different letters were significantly different when the interaction was significant (P < 0.05).